Total Funding
8
25
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
811358
SpePharm is a pharmaceutical company focused on acquiring, registering and marketing medicines throughout Europe.
Jean-François Labbé: Managing Director and Chief Executive OfficerPast Role: Hoechst Marion Roussel, President Europe-Middle East-Africa
James C. Gale: Bord of DirectorsPast Role: Gruntal & Co, Head of Principal Investment Activities & Investment Banking
About the Company
SpePharm is a European specialty pharmaceutical company dedicated to acquiring, registering and marketing high medical value medicines throughout Europe, essentially for the hospital market. The SpePharm management team has a wealth of global experience within the pharmaceutical industry. In particular, the team has a well-established and in-depth
knowledge of the European regulatory system, the hospital market, and niche and orphan products, with novel approaches and proven successes.
